rhb7 h3 fc fusion (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
rhb7 h3 fc fusion
Rhb7 H3 Fc Fusion, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+b7+h3+fc+fusion+protein/Recombinant+Human+B7-H3+Fc+Chimera+Protein%2C+CF/us11434294-877-35-38
Average 94 stars, based on 16 article reviews
Rhb7 H3 Fc Fusion, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+b7+h3+fc+fusion+protein/Recombinant+Human+B7-H3+Fc+Chimera+Protein%2C+CF/us11434294-877-35-38
Average 94 stars, based on 16 article reviews
rhb7 h3 fc fusion - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Staining:Article Title: Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases Article Snippet: Antigen retrieval and staining for human B7-H3 was conducted with the use of affinity-purified goat anti-human B7-H3 antibody (R&D Systems; 100 μg/mL) diluted 1:80 with Da Vinci Green antibody diluent (Biocare Medical) as previously described ( 19 ). .. As controls for specificity of staining, B7-H3 staining was blocked with the use of 1:30 Article Title: Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases Article Snippet: Antigen retrieval and staining for human B7-H3 was conducted with the use of affinitypurified goat anti-human B7-H3 antibody (R&D Systems; 100 Ag/mL) diluted 1:80 with Da Vinci Green antibody diluent (Biocare Medical) as previously described (19). .. As controls for specificity of staining, B7-H3 staining was blocked with the use of 1:30 Article Title: Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Article Snippet: ALEXANDER S. PARKER, PH.D.,* MICHAEL G. HECKMAN, M.S.,*y YURI SHEININ, M.D., PH.D.,z KEVIN J. WU, M.D.,* TRACY W. HILTON, B.S.,* NANCY N. DIEHL, B.S.,*y THOMAS M. PISANSKY, M.D.,z STEVEN E. SCHILD, M.D.,x EUGENE D. KWON, M.D.,z AND STEVEN J. BUSKIRK, M.D.. * From the *College of Medicine and yBiostatistics Unit, Mayo Clinic Florida, Jacksonville, FL; zMayo Clinic Rochester, Rochester, MN; and xMayo Clinic Arizona, Scottsadale, AZ Control:Article Title: Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Article Snippet: ALEXANDER S. PARKER, PH.D.,* MICHAEL G. HECKMAN, M.S.,*y YURI SHEININ, M.D., PH.D.,z KEVIN J. WU, M.D.,* TRACY W. HILTON, B.S.,* NANCY N. DIEHL, B.S.,*y THOMAS M. PISANSKY, M.D.,z STEVEN E. SCHILD, M.D.,x EUGENE D. KWON, M.D.,z AND STEVEN J. BUSKIRK, M.D.. * From the *College of Medicine and yBiostatistics Unit, Mayo Clinic Florida, Jacksonville, FL; zMayo Clinic Rochester, Rochester, MN; and xMayo Clinic Arizona, Scottsadale, AZ |